Despite the significant effectiveness of antithrombotic medications and the growing availability of oral anticoagulants, preventable bleeding and thrombotic events remain unacceptably common. Newly introduced agents may require less frequent laboratory monitoring; however, challenges persist in the clinical management of anticoagulated patients, especially during the peri-procedural period.
Surgical procedures and invasive medical interventions elevate the risk of bleeding, while discontinuing anticoagulants raises the risk of thrombosis given the initial indication for anticoagulation. Hence, the clinical team faces the crucial task of balancing these risks and making informed decisions regarding interrupting oral anticoagulation for medical procedures. Furthermore, if interruption is deemed necessary, the choice of whether to "bridge" anticoagulation with injectable agents like low molecular weight heparin (LMWH) in patients on warfarin must be carefully considered.
This comprehensive guide aims to:
- Assist healthcare providers in evaluating both procedure-related bleeding risks and underlying thrombosis risks simultaneously
- Offer guidance on decisions concerning anticoagulation interruption and the utilization of anticoagulant "bridging"
- Provide detailed recommendations on drug dosing and laboratory monitoring during the peri-procedural phase
- Promote clear communication among clinicians responsible for prescribing anticoagulants and carrying out invasive procedures
This resource was developed by the interdisciplinary Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, which serves as the Medicare Quality Improvement Organization for New York State. The project was undertaken under contract with the Centers for Medicare & Medicaid Services (CMS), an agency within the U.S. Department of Health and Human Services. Please note that the contents do not necessarily represent CMS policy. Reference: 10SOW-NY-AIM-7.3-14-01
Visão geral
MAPPP é um software Freeware a categoria (2) desenvolvido pela Island Peer Review Organization, Inc.
É a versão mais recente de MAPPP 1.2.71, lançado em 17/09/2024. Inicialmente foi adicionado ao nosso banco de dados em 17/09/2024.
MAPPP é executado nos seguintes sistemas operacionais: iOS.
Usuários de MAPPP deram-lhe uma classificação de 4 de 5 estrelas.
Produtos relacionados
27/09/2024 | HWMonitor 1.55 |
27/09/2024 | Razer Axon 1.7.2 |
27/09/2024 | NoScript 11.4.40 |
27/09/2024 | MailWasher Free 7.15.12 |
27/09/2024 | Resharper 2024.2.5 |
com o UpdateStar gratuito.
27/09/2024 | Microsoft 365: We present the best freealternatives. |
26/09/2024 | TeamViewer 15.58.4 update available |
24/09/2024 | Five compelling reasons to use a VPN service in 2024 |
21/09/2024 | The best Windows cleaning tools for 2025 |
18/09/2024 | Google Browser: Chrome 129 available |